Cereno Scientific announces insider share purchases by the Board and management
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced insider share purchases have been completed. Joakim Söderström, Cereno’s Chair of the Board, purchased 1,240,000 shares on June 27, 2023, to a value of 0.648 per share on the Nasdaq First North Growth Market marketplace. Sten R. Sörensen, Cereno’s CEO, purchased 144,000 shares on June 28, 2023, to a value of 0.69 per share on the Nasdaq First North Growth Market marketplace.“As the newly appointed Chair of the Board, I have a very positive